Sarcoma ecotypes determine immunotherapy benefit

Competing interests

S.F. reports consultancy fees from Bayer, Illumina and Roche; honoraria from Amgen, Eli Lilly, PharmaMar and Roche; research funding from AstraZeneca, Pfizer, PharmaMar and Roche; and travel or accommodation expense reimbursement from Amgen, Eli Lilly, Illumina, PharmaMar and Roche.

Comments (0)

No login
gif